白细胞介素-1β在子宫内膜异位症神经生长因子表达、神经发生及深部性交痛中的作用
该体外研究纳入45例子宫内膜异位症组织,发现IL-1β直接刺激NGF表达,并与病灶周围神经发生及更严重的深部性交痛相关;原代基质细胞实验显示IL-1β通过IL-1R1/c-FOS通路上调NGF,其条件培养基可促进PC-12细胞神经突生长,并可被NGF中和抗体或Anakinra减弱。
要点
- IL-1β刺激子宫内膜异位症NGF表达并促进局部神经发生。
- IL-1β表达与更严重的深部性交痛及神经纤维密度相关。
- Anakinra或NGF中和抗体可减弱IL-1β诱导的神经突生长。
核心结论
- IL-1β直接刺激子宫内膜异位症NGF表达,与病灶周围局部神经发生及更严重的深部性交痛相关。
研究设计与样本
- 体外研究,纳入45例子宫内膜异位症组织样本,包括深部浸润型12例、卵巢子宫内膜异位囊肿14例、浅表腹膜型19例。
- 采用免疫组化半定量评估IL-1β、IL-1R1、NGF和PGP9.5表达,并分离培养原代子宫内膜异位症基质细胞进行干预实验。
- 深部性交痛由患者术前采用11点数字评分量表(0-10)评定。
主要发现
- 子宫内膜异位症上皮IL-1β表达与更严重深部性交痛显著相关(r=0.37,P=0.02)。
- 上皮IL-1β表达与病灶周围神经纤维束密度相关(r=0.42,P=0.01)。
- 上皮IL-1β表达与上皮NGF表达(r=0.42,P=0.01)及间质NGF表达(r=0.45,P=0.01)相关。
- 外源性IL-1β显著增加原代基质细胞NGF和c-FOS的mRNA及蛋白水平。
- Anakinra、IL-1R1 siRNA或c-FOS siRNA预处理均减弱IL-1β诱导的NGF表达增加。
关键数值与推荐
- 深部性交痛采用11点数字评分量表(0-10)评定。
- 免疫组化染色强度采用Histoscore法(H-score)半定量评估。
临床怎么用
- IL-1β/NGF轴可能作为子宫内膜异位症相关深部性交痛的潜在药物靶点。
局限性
- 未获得子宫内膜异位症腺上皮原代培养数据,因该细胞类型原代培养存在已知困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does interleukin-1β (IL-1β) play a role in promoting nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis? SUMMARY ANSWER: IL-1β directly stimulates nerve growth factor (NGF) expression in endometriosis and is associated with local neurogenesis around endometriosis and more severe deep dyspareunia. WHAT IS KNOWN ALREADY: Local nerve density around endometriosis (using the pan-neuronal marker PGP9.5) is associated with deep dyspareunia in endometriosis, mediated in part by NGF expression. STUDY DESIGN, SIZE, DURATION: This in vitro study included endometriotic tissue samples from 45 patients. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study was conducted in a university hospital affiliated research institute and included 45 women with surgically excised deep uterosacral/rectovaginal endometriosis (DIE, n = 12), ovarian endometriomas (OMA, n = 14) or superficial peritoneal uterosacral/cul-de-sac endometriosis (SUP, n = 19). Immunolocalisation of IL-1β, IL-1 receptor type 1 (IL-1R1), NGF and PGP9.5 in endometriotic tissues was examined by immunohistochemistry (IHC), and the intensity of IHC staining in the endometriotic epithelium and stroma was semi-quantitatively evaluated using the Histoscore method (H-score). For each case, deep dyspareunia was pre-operatively rated by the patient on an 11-point numeric rating scale (0-10). In addition, primary endometriosis stromal cells were isolated and cultured from surgically excised endometriosis. These cells were treated with IL-1β alone or in combination of Anakinra (an inhibitor of IL-1R1), small inference RNA (siRNA) against IL-1R1, siRNA against c-FOS or NGF neutralising antibody. The mRNA and protein levels of target genes (NGF and c-FOS) were assessed by reverse-transcription qPCR and western blot/ELISA, respectively. Furthermore, immunofluorescent microscopy was used to examine the neurite growth of rat pheochromocytoma PC-12 cells, as an in vitro model of neurogenesis. MAIN RESULTS AND THE ROLE OF CHANCE: For IHC, IL-1β expression in the endometriosis epithelium was significantly associated with more severe deep dyspareunia (r = 0.37, P = 0.02), higher nerve fibre bundle density around endometriosis (r = 0.42, P = 0.01) and greater NGF expression by the endometriosis epithelium (r = 0.42, P = 0.01) and stroma (r = 0.45, P = 0.01). In primary endometriosis stromal cells, treatment with exogenous IL-1β significantly increased the mRNA and protein levels of NGF and c-FOS. Pre-treatment with Anakinra, siRNA against IL-1R1, or siRNA against c-FOS, each attenuated IL-1 β-induced increases of NGF expression. In addition, supernatants from IL-1β treated endometriosis stromal cells significantly stimulated PC-12 neurite growth compared to controls, and these effects could be attenuated by pre-treatment with NGF neutralising antibody or Anakinra. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: We did not have data from cultures of endometriosis glandular epithelium, due to the known difficulties with primary cultures of this cell type. WIDER IMPLICATIONS OF THE FINDINGS: Our study revealed a mechanism for deep dyspareunia in endometriosis, whereby IL-1β stimulates NGF expression, promoting local neurogenesis around endometriosis, which in turn leads to tender pelvic anatomic sites and thus deep-hitting dyspareunia. There may also be potential for drug targeting of IL-1β and/or NGF in the management of endometriosis-associated pain. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by grants from the Canadian Institutes of Health Research (MOP-142273 and PJT-156084). P.Y. is also supported by a Health Professional Investigator Award from the Michael Smith Foundation for Health Research. MB has financial affiliations with Abbvie and Allergan. Otherwise, there are no conflicts of interest to declare.
引用
- Peng B, Alotaibi FT, Sediqi S, et al. Role of interleukin-1β in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis. Hum Reprod. 2020. PMID: 32240297. doi:10.1093/humrep/deaa017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。